Positive late stage rheumatoid arthritis trial results for Abbvie
admin 29th May 2019 Uncategorised 0Upadacitinib was found to have achieved both primary endpoints with significantly higher rates of ACR20 response and low disease activity at week 14.
More: Positive late stage rheumatoid arthritis trial results for Abbvie
Source: News